Severe acute respiratory syndrome (SARS) is an illness caused by a coronavirus. Symptoms including a high fever, headaches, and body aches typically occur two to seven days after infection by the virus. SARS is more serious in elderly patients. This information suggests that the reproductive cycle of the SARS virus is-Responseslytic, because the virus causes respiratory illnesslytic, because the virus causes respiratory illnesslysogenic, because the virus is a coronaviruslysogenic, because the virus is a coronaviruslytic, because of the quick onset of symptoms after infectionlytic, because of the quick onset of symptoms after infectionlysogenic, because the virus primarily affects older people
Question
Severe acute respiratory syndrome (SARS) is an illness caused by a coronavirus. Symptoms including a high fever, headaches, and body aches typically occur two to seven days after infection by the virus. SARS is more serious in elderly patients. This information suggests that the reproductive cycle of the SARS virus is-Responseslytic, because the virus causes respiratory illnesslytic, because the virus causes respiratory illnesslysogenic, because the virus is a coronaviruslysogenic, because the virus is a coronaviruslytic, because of the quick onset of symptoms after infectionlytic, because of the quick onset of symptoms after infectionlysogenic, because the virus primarily affects older people
Solution
The reproductive cycle of the SARS virus is lytic, because of the quick onset of symptoms after infection. This is because in a lytic cycle, the virus takes control of the host cell, reproduces itself, and then causes the cell to burst, which can lead to symptoms. This process is typically quick, aligning with the 2-7 day onset period of SARS symptoms.
Similar Questions
The full form of SARS is*2 pointsSeveral Acute Respiratory SyndromeSevere Acute Reverse SyndromeSevere Acute Respiratory SystemSevere Acute Respiratory Syndrome
SARS caused a health panic in 2003 in many areas around the world. SARS stands for:Select one:a.Severe acute respiratory syndromeb.Severe Acute Regulatory Systemc.Sustainable access red sead.Stress around relaxed sites
Monoclonal antibodies (mAbs) neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were the first antiviral drugs specifically developed for the treatment and prophylaxis of coronavirus disease 2019 (COVID-19) (1). Emergence of variants of concern (VOC) resistant to such antibodies on population level, however, limits their broad applicability. The Omicron variants, for example, are only neutralized by a small subset of monoclonal antibodies developed for the treatment of SARS-CoV-2 infections (2, 3). As more variants emerge, having a repertoire of monoclonal antibodies targeting different sites of the Spike protein may become useful. Therefore, we explored the prophylactic efficacy of two monoclonal antibodies targeting the receptor binding domain (RBD) of SARS-CoV-2 in a nonhuman primate model of SARS-CoV-2 infection. We additionally investigated their genetic barrier to resistance in vivo and in vitro.
The disease COVID-19 is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). The virus was first identified at the beginning of 2020, and has since gone on to cause a pandemic. It is currently believed that SARS-CoV-2 is an example of a zoonosis.Throughout 2020, much of the world’s medical scientific community was devoted to developing a vaccine for SARS-CoV-2. To evaluate the effectiveness of new vaccines, both humoral and cell-mediated responses are measured in animal subjects. Identify the cell type that is involved in both responses, and explain its role in each.
The animal host for SARS-CoV-2 is the . After circulating among these animals in the wild for a long period of time, the virus accumulated mutations that allowed infection of humans.
Upgrade your grade with Knowee
Get personalized homework help. Review tough concepts in more detail, or go deeper into your topic by exploring other relevant questions.